|
|
 |
Trial Information
Summary: Examination of PNH, by Level Of CD59 on REd and white blood cells, in bone marrow failure syndromes (EXPLORE)
** This study is an observational prevelance study.
The primary objectives are to determine the occurrence of Paroxysmal Nocturnal Hemoglobinuria (PNH) cells in people with Aplastic Anemia (AA), Myelodysplastic Syndromes (MDS), and other bone marrow failure syndromes.
The secondary objectives are to understand the relationship between different bone marrow failure syndromes and the different characteristics of PNH.
Patient Inclusion Criteria:
- Is at least 18 years of age.
- Is willing to comply with the protocol.
- Is willing and able to give written informed consent.
- Has AA, MDS, or other bone marrow failure syndromes.
Patient Exclusion Criteria:
See www.hsc.wvu.edu/mbrcc/ctru/ for additional information.
|
Contact:
West Virginia University - Clinical Trials Research Unit
1637 Health Sciences South
PO Box 9260
Morgantown, WV 26506
Telephone: 304-293-7374
|
|

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 6:42:53 AM
|
 |
|